Follow the link of the selected polymorphism to read a brief description of how the selected polymorphism affects Myocardial infarction and see a list of existing studies.
SNP polymorphisms related to the topic Myocardial infarction:
|The A2 allele of the platelet-specific alloantigen system is encoded by rs5918(C), it is associated with increased risk of myocardial infarction, heart disease and resistance to the blood thinning properties of aspirin.
|The rs46522 polymorphism of the E2Z ubiquitin-conjugating enzyme gene is associated with abnormal metabolic parameters in patients with myocardial infarction.
|A new locus of coronary atherosclerosis and associations with myocardial infarction in coronary atherosclerosis.
|Intronic polymorphisms in the CDKN2B-AS1 gene are strongly associated with the risk of myocardial infarction and coronary heart disease.
|A single nucleotide polymorphism in the LIPA (lysosomal acidic lipase A) gene is associated with predisposition to premature coronary heart disease.
|Increased risk of sudden myocardial infarction and coronary heart disease.
|HHIPL-1 gene polymorphism (rs2895811) is associated with cardiovascular risk factors and cardiometabolic parameters in patients with myocardial infarction.
|rs3798220, also known as I4399M or Ile4399Met, is a SNP in the apolipoprotein (A) LPA gene , which has been reported to be associated with elevated plasma lipoprotein levels and increased cardiovascular risk, well-tolerated by low-dose aspirin.
|A genetic variant on chromosome 9p21 is the strongest genetic predictor of early myocardial infarction (heart attack) found so far. SNPs in this region are also associated with an increased risk of stroke, abdominal aortic aneurysm (AAA) and intracranial aneurysm.
|The polymorphism is associated with impaired proinsulin conversion and redisposition to type 2 diabetes.
|SNP of the MIA3 gene associated with increased risk of myocardial infarction with odds ratios of 1.17 (CI: 1.04-1.32) and 1.37 (CI: 1.08-1.74) for carriers.